Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients

Clinical trial NCT05819736 · COMPLETED

Trial details

NCT number: NCT05819736
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Anticoagulants and Thrombotic Disorders

Start date: 2022-12-01
Primary completion: 2026-05-18
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.